Roderick J. Johnson

1.6k total citations
39 papers, 934 citations indexed

About

Roderick J. Johnson is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Roderick J. Johnson has authored 39 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 14 papers in Oncology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Roderick J. Johnson's work include Lymphoma Diagnosis and Treatment (10 papers), Viral-associated cancers and disorders (7 papers) and Multiple Myeloma Research and Treatments (5 papers). Roderick J. Johnson is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Viral-associated cancers and disorders (7 papers) and Multiple Myeloma Research and Treatments (5 papers). Roderick J. Johnson collaborates with scholars based in United Kingdom, United States and France. Roderick J. Johnson's co-authors include H.H. Happ, Andy C. Rawstron, Gareth J. Morgan, Roger G. Owen, Graeme Smith, Andrew Jack, J. A. Child, L. Ollivier, John Spencer and Janet E. Husband and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Medicinal Chemistry.

In The Last Decade

Roderick J. Johnson

38 papers receiving 887 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roderick J. Johnson United Kingdom 17 349 234 191 149 124 39 934
Sudipto Mukherjee United States 17 573 1.6× 319 1.4× 258 1.4× 283 1.9× 152 1.2× 139 1.2k
Sangbum Choi United States 16 103 0.3× 210 0.9× 446 2.3× 70 0.5× 72 0.6× 68 1.4k
Joshua Fein United States 16 480 1.4× 354 1.5× 261 1.4× 405 2.7× 34 0.3× 46 1.2k
Mark‐David Levin Netherlands 20 431 1.2× 655 2.8× 289 1.5× 405 2.7× 89 0.7× 109 1.6k
Massimo Martino Italy 23 1.1k 3.2× 750 3.2× 428 2.2× 220 1.5× 44 0.4× 152 1.8k
Pam McKay United Kingdom 21 355 1.0× 443 1.9× 139 0.7× 524 3.5× 46 0.4× 77 1.4k
Cédric Rossi France 21 209 0.6× 355 1.5× 197 1.0× 214 1.4× 305 2.5× 77 1.3k
Kenji Yokoyama Japan 15 265 0.8× 149 0.6× 114 0.6× 103 0.7× 21 0.2× 57 820
Patricia S. Fox United States 27 91 0.3× 525 2.2× 266 1.4× 63 0.4× 452 3.6× 62 1.9k
Ciara M. Kelly United States 15 61 0.2× 520 2.2× 136 0.7× 87 0.6× 51 0.4× 64 1.1k

Countries citing papers authored by Roderick J. Johnson

Since Specialization
Citations

This map shows the geographic impact of Roderick J. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roderick J. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roderick J. Johnson more than expected).

Fields of papers citing papers by Roderick J. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roderick J. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roderick J. Johnson. The network helps show where Roderick J. Johnson may publish in the future.

Co-authorship network of co-authors of Roderick J. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Roderick J. Johnson. A scholar is included among the top collaborators of Roderick J. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roderick J. Johnson. Roderick J. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pettengell, Ruth, Ariane Boumendil, Roderick J. Johnson, et al.. (2021). Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial. Bone Marrow Transplantation. 56(6). 1413–1421. 7 indexed citations
2.
Ramchandren, Radhakrishnan, Peter Johnson, Nilanjan Ghosh, et al.. (2018). The iR2 Regimen(Ibrutinib, Lenalidomide, and Rituximab) Is Active with a Manageable Safety Profile in Patients with Relapsed/Refractory Non-Germinal Center-like Diffuse Large B-Cell Lymphoma. Blood. 132(Supplement 1). 402–402. 3 indexed citations
3.
Radford, John, Pam McKay, Ram Malladi, et al.. (2017). Treatment pathways and resource use associated with recurrent Hodgkin lymphoma after autologous stem cell transplantation. Bone Marrow Transplantation. 52(3). 452–454. 3 indexed citations
4.
Johnson, Roderick J., et al.. (2014). Resolution of methotrexate‐induced Epstein‐Barr virus‐associated mucocutaneous ulcer. British Journal of Haematology. 165(5). 584–584. 22 indexed citations
5.
Burns, David, Jennifer Marsh, Martin Rowe, et al.. (2013). Outcomes With Rituximab Monotherapy Versus R-CHOP In Post-Transplant Lymphoproliferative Disease Arising After Solid Organ Transplant: A Multicentre UK Study. Blood. 122(21). 3043–3043. 1 indexed citations
6.
Johnson, Roderick J., Andrew Davies, Siow Ming Lee, et al.. (2012). A Phase 1 Trial of Escalating High Dose Methotrexate Supported by Glucarpidase to Treat Patients with Primary Central Nervous System Lymphoma (PCNSL). (CRUK/08/010). Blood. 120(21). 4850–4850. 1 indexed citations
7.
Feyler, Sylvia, Andy C. Rawstron, Graham Jackson, et al.. (2007). Thalidomide maintenance following high‐dose therapy in multiple myeloma: a UK myeloma forum phase 2 study. British Journal of Haematology. 139(3). 429–433. 28 indexed citations
8.
Husband, Janet E., Lawrence H. Schwartz, John Spencer, et al.. (2004). Evaluation of the response to treatment of solid tumours – a consensus statement of the International Cancer Imaging Society. British Journal of Cancer. 90(12). 2256–2260. 130 indexed citations
9.
Laasch, Hans‐Ulrich, L. Wilbraham, Anna Marriott, et al.. (2003). Gastrostomy Insertion: Comparing the Options—PEG, RIG or PIG?. Clinical Radiology. 58(5). 398–405. 85 indexed citations
10.
Schey, Stephen, Jamie Cavenagh, Roderick J. Johnson, et al.. (2003). An UK myeloma forum phase II study of thalidomide; long term follow-up and recommendations for treatment. Leukemia Research. 27(10). 909–914. 52 indexed citations
11.
Dodson, P M, Jane Starczynski, John A. Farmer, et al.. (2003). The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion. Eye. 17(6). 772–777. 25 indexed citations
12.
Johnson, Roderick J.. (2002). Paroxysmal nocturnal haemoglobinuria: Nature's gene therapy?. Molecular Pathology. 55(3). 145–152. 33 indexed citations
13.
Pratt, Guy, Andy C. Rawstron, Roderick J. Johnson, et al.. (2001). Analysis of CD34+ cell subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34+ cell dose, but steady state levels do not correlate with bone marrow reserve. British Journal of Haematology. 114(4). 937–943. 18 indexed citations
14.
Rawstron, Andy C., Roger G. Owen, Faith E. Davies, et al.. (1997). Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage. British Journal of Haematology. 97(1). 46–55. 151 indexed citations
15.
Johnson, Roderick J. & Graeme Smith. (1997). Mobilisation and Reinfusion of Philadelphia Negative Peripheral Blood Mononuclear Cells in Chronic Myeloid Leukaemia with Hydroxyurea and G-CSF. Leukemia & lymphoma. 27(5-6). 401–415. 5 indexed citations
16.
Johnson, Roderick J., Roger G. Owen, J. A. Child, et al.. (1996). MOBILIZATION OF PHILADELPHIA‐NEGATIVE PERIPHERAL BLOOD MONONUCLEAR CELLS IN CHRONIC MYELOID LEUKAEMIA USING HYDROXYUREA AND G‐CSF (FILGRASTIM). British Journal of Haematology. 93(4). 863–868. 20 indexed citations
17.
Clarke, Deborah, Peter Johnson, Rosamonde E. Banks, et al.. (1996). EFFECTS OF INTERLEUKIN 6 ADMINISTRATION ON PLATELETS AND HAEMOPOIETIC PROGENITOR CELLS IN PERIPHERAL BLOOD. Cytokine. 8(9). 717–723. 29 indexed citations
18.
19.
Hanks, Gerald E., M.V. Pilepich, John M. Krall, et al.. (1986). The adverse effect of turp as method of diagnosis in 494 patients with stage C prostate cancer treated within RTOG protocol 75-06. International Journal of Radiation Oncology*Biology*Physics. 12. 106–106. 2 indexed citations
20.
Martens, Anton C., Roderick J. Johnson, Herbert Kaizer, & Anton Hagenbeek. (1984). Characteristics of a monoclonal antibody (RM124) against acute myelocytic leukemia cells.. PubMed. 12(8). 667–71. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sudipto Mukherjee Breakdown of academic impact, for papers by Sangbum Choi Breakdown of academic impact, for papers by Joshua Fein Breakdown of academic impact, for papers by Mark‐David Levin Breakdown of academic impact, for papers by Massimo Martino Breakdown of academic impact, for papers by Pam McKay Breakdown of academic impact, for papers by Cédric Rossi Breakdown of academic impact, for papers by Kenji Yokoyama Breakdown of academic impact, for papers by Patricia S. Fox Breakdown of academic impact, for papers by Ciara M. Kelly
Rankless by CCL
2026